SC
EXAS

Syon Capital’s Exact Sciences EXAS Stock Holding History

Syon Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,520
Closed -$760K – 607
2024
Q4 		$760K Buy
+13,520
New +$841K 0.07% 196
2024
Q1 		– Sell
-2,901
Closed -$215K – 474
2023
Q4 		$215K Buy
+2,901
New +$190K 0.01% 466

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Syon Capital's EXAS Position: Q1 2025 in Review

Syon Capital sold out of Exact Sciences (EXAS) in Q1 2025, closing a stake of 13,520 shares — an estimated $760K sold.

Syon Capital first reported a position in EXAS in Q4 2023 and held it in 2 quarters. The position peaked at $760K in Q4 2024. 557 funds tracked by Wall St. Rank hold EXAS as of Q1 2025.

  • Syon Capital reported no remaining Exact Sciences position as of Q1 2025 after selling out during the quarter.
  • Syon Capital sold 13,520 Exact Sciences shares in Q1 2025, an estimated $760K.
  • Syon Capital first reported a position in Exact Sciences in Q4 2023 and held it in 2 quarters.
  • Syon Capital's Exact Sciences position peaked at $760K in Q4 2024.
  • 557 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2025.

Based on Syon Capital's 13F filing for Q1 2025, filed 15 May 2025.